MAPK9 (mitogen-activated protein kinase 9)
2003-01-01 Fei Chen   AffiliationHealth Effects Laboratory Division, NIOSH, 1095 Willowdale Rd, Morgantown, WV 26505, USA
Identity
HGNC
LOCATION
5q35.3
LOCUSID
ALIAS
JNK-55,JNK2,JNK2A,JNK2ALPHA,JNK2B,JNK2BETA,PRKM9,SAPK,SAPK1a,p54a,p54aSAPK
FUSION GENES
DNA/RNA
Description
The JNK2 gene maps on chromosome 5q35 spanning 58494bp. It contains 17 confirmed introns, 14 of which are alternative.
Transcription
By alternative splicing, JNK2 gene encodes 12 types of transcripts that translate to 12 distinct JNK2 isoforms. The molecular weight of JNK2 is about 55 kD.
Proteins
Description
All JNK proteins contain a protein kinase domain that belong to a very extensive family of eukaryotic serine/threonine proteins kinase. A number of conserved regions have been identified in the catalytic domain of JNKs. In the N-terminal extremity of the catalytic domain there is a glycine-rich motif in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. A conserved aspartic acid reside that is critical for the catalytic activity of kinase has also been identified in the central part of the catalytic domain.
Expression
JNK1 is ubiquitously expressed.
Localisation
Cytoplasmic and nuclear
Function
The members of JNK family act as an integration point for multiple intracellular biochemical signals governing a wide variety of cellular processes such as proliferation, differentiation, apoptosis, migration, transcriptional regulation, and development.
JNK targets specific transcription factors and thus mediates immediate-early gene expression in response to various stress signals including ultraviolet (UV) radiation, oxidative stress, protein malfolding in endoplasmic reticulum, osmotical shock, and inflammatory mediators. These transcription factors include AP-1, ATF-2, Elk-1, p53, etc... Several upstream dual specific protein kinases, such as MKK4/SEK1 and MKK7, can activate JNK through phosphorylation of the conversed Thr-Pro-Tyr motif on JNK proteins. In mammalian cells, activated JNK can phosphorylate the N-terminus of c-Jun, which contains both JNK docking site and JNK phosphorylation site (ser63 and ser73), orJunD, which lacks a JNK docking site but contains a JNK phosphorylation site. JNK is unable to phosphorylate JunB due to the lack of a JNK phosphorylation site inJunB, despite there is a functional JNK docking site. Comparison of the binding activity of JNK isoforms demonstrates that JNK2 bind c-Jun approximately 25 times more efficiently than did JNK1. Therefore, individual members of the JNK family may selectively target specific transcription factors in vivo.
One of the most important functions of JNK is the regulation of apoptosis. Emerging evidence indicates that JNK activation is obligatory for apoptosis induced by both receptor-mediated "extrinsic" pathway or mitochondria-mediated "intrinsic" pathway. JNK activation may contribute to the initiation of Fas-induced apoptosis, possibly through the amplification of autocrine or paracrine Fas signaling by JNK-dependent Fas ligand (FasL) gene expression. In addition, JNK has been indicated in the apoptosis induced by Daxx, a Fas death domain (FADD) interaction protein. Through its serine/threonine kinase activity, JNK may contribute to mitochondria-mediated apoptosis by phosphorylating pro- or anti-apoptoticBcl-2 family proteins. Finally, JNK has also been indicated as an important kinase phosphorylating p53 and subsequently facilitating p53-dependent apoptotic responses.
Sustained JNK activation may be responsible for the enhanced apoptosis observed in RelA-/- or Ikkb-/- mouse embryonic fibroblasts treated with TNFa. It was suggested that deficiency of RelA or IKKb caused a decreased expression of XIAP or GADD45b, which may antagonize the activation of JNK activation. However, such speculation contradicts the previous observations indicating that both GADD45b and XIAP are activators, rather than inhibitors for JNK activation. Moreover, gene profiling in our recent studies indicated no substantial difference of basal or inducible GADD45b and XIAP mRNA in wild type cells and Ikkb-/- cells.
Implicated in
Entity name
Obesity, insulin resistance, neurodegenerative diseases, inflammation, cancer.
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 11057897 | 2000 | Signal transduction by the JNK group of MAP kinases. | Davis RJ et al |
| 11713530 | 2001 | Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. | De Smaele E et al |
| 9710625 | 1998 | Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter. | Faris M et al |
| 9732264 | 1998 | JNK targets p53 ubiquitination and degradation in nonstressed cells. | Fuchs SY et al |
| 9925641 | 1999 | Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. | Jacobs D et al |
| 8001819 | 1994 | JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. | Kallunki T et al |
| 11447297 | 2001 | Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. | Suzuki Y et al |
| 9827804 | 1998 | A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. | Takekawa M et al |
| 11713531 | 2001 | Inhibition of JNK activation through NF-kappaB target genes. | Tang G et al |
| 9215629 | 1997 | Daxx, a novel Fas-binding protein that activates JNK and apoptosis. | Yang X et al |
Other Information
Locus ID:
NCBI: 5601
MIM: 602896
HGNC: 6886
Ensembl: ENSG00000050748
Variants:
dbSNP: 5601
ClinVar: 5601
TCGA: ENSG00000050748
COSMIC: MAPK9
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA284 | MAP2K7 | Gene | Pathway | associated | 20124951 | ||
| PA30584 | MAP2K1 | Gene | Pathway | associated | 20124951 | ||
| PA30587 | MAP2K2 | Gene | Pathway | associated | 20124951 | ||
| PA30588 | MAP2K3 | Gene | Pathway | associated | 20124951 | ||
| PA30589 | MAP2K4 | Gene | Pathway | associated | 20124951 | ||
| PA30590 | MAP2K5 | Gene | Pathway | associated | 20124951 | ||
| PA30591 | MAP2K6 | Gene | Pathway | associated | 20124951 | ||
| PA7000 | sorafenib | Chemical | Pathway | associated | 20124951 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38159171 | 2024 | Overexpression of circZNF720 Inhibits Hepatocellular Carcinoma Progression by Regulating miR-421/MAPK9. | 0 |
| 38163874 | 2024 | Circ_MAPK9 promotes STAT3 and LDHA expression by silencing miR-642b-3p and affects the progression of hepatocellular carcinoma. | 1 |
| 38159171 | 2024 | Overexpression of circZNF720 Inhibits Hepatocellular Carcinoma Progression by Regulating miR-421/MAPK9. | 0 |
| 38163874 | 2024 | Circ_MAPK9 promotes STAT3 and LDHA expression by silencing miR-642b-3p and affects the progression of hepatocellular carcinoma. | 1 |
| 37957865 | 2023 | JNK2 Promotes Progression of Esophageal Squamous Cell Carcinoma via Inhibiting Axin2. | 0 |
| 37957865 | 2023 | JNK2 Promotes Progression of Esophageal Squamous Cell Carcinoma via Inhibiting Axin2. | 0 |
| 33526844 | 2022 | c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1. | 6 |
| 33526844 | 2022 | c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1. | 6 |
| 34502556 | 2021 | The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases. | 16 |
| 34899681 | 2021 | miR-221-5p-Mediated Downregulation of JNK2 Aggravates Acute Lung Injury. | 7 |
| 34962918 | 2021 | c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease. | 5 |
| 34502556 | 2021 | The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases. | 16 |
| 34899681 | 2021 | miR-221-5p-Mediated Downregulation of JNK2 Aggravates Acute Lung Injury. | 7 |
| 34962918 | 2021 | c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease. | 5 |
| 31063355 | 2019 | JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells. | 11 |
Citation
Fei Chen
MAPK9 (mitogen-activated protein kinase 9)
Atlas Genet Cytogenet Oncol Haematol. 2003-01-01
Online version: http://atlasgeneticsoncology.org/gene/426/mapk9-(mitogen-activated-protein-kinase-9)
